“Recover quickly and be discharged after 3 days!” On September 8th, Wang Jian, director of the Department of Hand Surgery in the First Affiliated Hospital of Wenzhou Medical University, checked the patient’s wound and determined the discharge time. Aunt Xu, who is in her 60 s, thanked her for the good news. At this time, it was only more than 10 days since she was admitted to the hospital: “In the past, my injury required three operations. I didn’t expect that the wound would begin to recover only one week after the first operation.” The magic prescription that brought her quick repair came from the “growth factor” developed by the team of Academician Li Xiaojian of Wenzhou Medical University.
Imagine: the gecko’s tail is broken and can grow again because there is a factor that can promote it to grow again. In fact, there are also such cytokines in human body, that is, fibroblast growth factor. Li Xiaojian, president of Wenzhou Medical University and academician of China Academy of Engineering, led the team to solve the key difficulties such as insufficient drug source and difficult extraction of growth factor through gene technology, making China the first country in the world to develop fibroblast growth factor into a new class of drugs, benefiting the treatment of major catastrophic trauma, national defense war injury, ulcer and accelerated tissue regeneration, and various complications of diabetic foot.
“The traditional treatment method is to remove necrotic skin surgery first, and then perform about two flap operations, but there is a certain risk of necrosis.” Wang Jian said that after Aunt Xu’s first operation, they implemented the treatment method of continuous irrigation and negative pressure drainage with growth factors. After about one week, fresh and healthy granulation tissue began to grow. This is of great help to patients in shortening wound healing time, relieving trauma pain, reducing psychological pressure and recovering limb function in the follow-up.
In Wang Jian’s department, there are about 100 operations related to wounds and wounds every month. These wounds, wounds and surgical incisions caused by trauma, after the application of growth factors, the wounds and refractory wounds heal faster, and the scars are not obvious after healing, and the appearance is beautiful. In China, the number of patients who use growth factor drugs to treat traumatic wounds and wounds is more considerable. Up to now, new drugs such as fibroblast growth factor have been applied in many large hospitals across the country, serving more than 70 million patients.
“Recently, we have several drugs about to enter clinical trials, and one is in the second phase of clinical trials and will be put into production in China Gene Medicine Valley in the future.” Li Xiaoqi said that these new drugs containing fibroblast growth factor will play a great role in the fields of eye injury repair, metabolic diseases and central nervous system diseases treatment.
(Source: Zhejiang Daily)